Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017
Cancer Science · 2023-07 · 114 (7) · 2986-2992
DOI: 10.1111/cas.15823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 24.04.2023. Verfasst von Dai Ogata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Hemangiosarcoma, Skin Neoplasms, Basal Cell Carcinoma. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center Research and Development Fund.
Abstract (Originalsprache)
Skin cancer is most frequently diagnosed in the White population. However, its subtypes and epidemiology in Japan are understudied. We aimed to elucidate skin cancer incidence in Japan based on the National Cancer Registry, a new nationwide integrated population‐based registry. Data from patients diagnosed with skin cancer in 2016 and 2017 were extracted and classified by cancer subtypes. Data were analyzed using the World Health Organization and General Rules tumor classifications. Tumor incidence was calculated as the number of new cases divided by the corresponding total person‐years. Overall, 67,867 patients with skin cancer were included. The percentage of each subtype was as follows: basal cell carcinoma, 37.2%; squamous cell carcinoma, 43.9% (18.3% of which, in situ); malignant melanoma, 7.2% (22.1% of which, in situ); extramammary Paget's disease, 3.1% (24.9% of which, in situ); adnexal carcinoma, 2.9%; dermatofibrosarcoma protuberans, 0.9%; Merkel cell carcinoma, 0.6%; angiosarcoma, 0.5%; and hematologic malignancies, 3.8%. The overall age‐adjusted incidence of skin cancer was 27.89 for the Japanese population model and 9.28 for the World Health Organization (WHO) model. The incidences of basal cell carcinoma and squamous cell carcinoma were the highest (3.63 and 3.40 per 100,000 persons, respectively, in the WHO model) among skin cancers, whereas the incidences of angiosarcoma and Merkel cell carcinoma were the lowest (0.026 and 0.038 per 100,000 persons, respectively, in the WHO model). This is the first report to provide comprehensive information on the epidemiological status of skin cancers in Japan using population‐based NCR data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
- Rare Cancer Center, National Cancer Center, Tokyo, Japan.
- Department of Public Health/Health Policy, the University of Tokyo, Tokyo, Japan.
- Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Dai Ogata, Kenjiro Namikawa, Maiko Fujimori, Takahiro Higashi, Naoya Yamazaki, Akira Kawai
Förderung
- National Cancer Center Research and Development Fund
Zitieren
APA
Ogata, D., Namikawa, K., Nakano, E., Fujimori, M., Uchitomi, Y., Higashi, T., Yamazaki, N., & Kawai, A. (2023). Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017. Cancer Science, 114(7), 2986-2992. https://doi.org/10.1111/cas.15823
Vancouver
Ogata D, Namikawa K, Nakano E, Fujimori M, Uchitomi Y, Higashi T, et al. Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017. Cancer Science. 2023;114(7):2986-2992. doi:10.1111/cas.15823
BibTeX
@article{Ogata2023,
author = {Ogata, Dai and Namikawa, Kenjiro and Nakano, Eiji and Fujimori, Maiko and Uchitomi, Yosuke and Higashi, Takahiro and Yamazaki, Naoya and Kawai, Akira},
title = {Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {7},
pages = {2986--2992},
doi = {10.1111/cas.15823}
}
EUVIMED